Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization

WAF1, a potential mediator of p53 tumor suppression

El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.

Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651

Cancer Cell Cycles

Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379

Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a

Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 2×

Mdm2 promotes the rapid degradation of p53

Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506

p21 is a universal inhibitor of cyclin kinases

Xiong, Y., Hannon, G., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,691

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.

Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650

Regulation of p53 stability by Mdm2

Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 2×

Induction of apoptosis in fibroblasts by c-myc protein

Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M. W., Waters, C. M., Penn, L. Z., & Hancock, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90123-t · Cited by 2,941

Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes

Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804

Viral-Mediated Noisy Gene Expression Reveals Biphasic E2f1 Response to MYC

Wong, J. V., Yao, G., Nevins, J. R., & You, L. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.01.014 · Cited by 46

A Transcriptional Logic for Nuclear Reprogramming

Rodolfa, K. T., & Eggan, K. C. (2006) · Cell · doi:10.1016/j.cell.2006.08.009 · Cited by 46

Modulation of signal transducer and activator of transcription 3 activities by p53 tumor suppressor in breast cancer cells.

Lin, J., Jin, X., Rothman, K., Lin, H.-J., Tang, H., & Burke, W. M. (2002) · PubMed · Cited by 46

Negative control elements of the cell cycle in human tumors

Adams, P. D., & Kaelin, W. G. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80123-3 · Cited by 46

MYC Oncogene: A Druggable Target for Treating Cancers with Natural Products

Chan, K. I., Zhang, S., Li, G., Xu, Y., Cui, L., Wang, Y., Su, H., Tan, W., & Zhong, Z. (2024) · Aging and Disease · doi:10.14336/ad.2023.0520 · Cited by 46

Induction of apoptosis by Drosophila Myc

Montero, L., Müller, N., & Gallant, P. (2008) · genesis · doi:10.1002/dvg.20373 · Cited by 45

ARF Directly Binds DP1: Interaction with DP1 Coincides with the G1 Arrest Function of ARF

Datta, A., Sen, J., Hagen, J., Korgaonkar, C. K., Caffrey, M. S., Quelle, D. E., Hughes, D. E., Ackerson, T. J., Costa, R. H., & Raychaudhuri, P. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.18.8024-8036.2005 · Cited by 46

The Novel ETS Factor TEL2 Cooperates with Myc in B Lymphomagenesis

Cardone, M., Kandilci, A., Carella, C., Nilsson, J. A., Brennan, J. A., Ekmekçi, S. S., Özbek, U., Boyd, K. L., Cleveland, J. L., & Grosveld, G. C. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.6.2395-2405.2005 · Cited by 45

Dual regulation of proliferation and apoptosis: c-myc in bitransgenic murine mammary tumor models

Jamerson, M. H., Johnson, M. D., & Dickson, R. B. (2000) · Oncogene · doi:10.1038/sj.onc.1203268 · Cited by 45

Simultaneous Drug Targeting of the Promoter MYC G-Quadruplex and BCL2 i-Motif in Diffuse Large B-Cell Lymphoma Delays Tumor Growth

Kendrick, S. L., Murányi, A., Gokhale, V. M., Hurley, L. H., & Rimsza, L. M. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00298 · Cited by 44

Bak functionally complements for loss of Bax during p14ARF-induced mitochondrial apoptosis in human cancer cells

Hemmati, P., Güner, D., Gillissen, B. F., Wendt, J., von Haefen, C., Chinnadurai, G., Dörken, B., & Daniel, P. T. (2006) · Oncogene · doi:10.1038/sj.onc.1209668 · Cited by 44

Induction of apoptosis in cancer: new therapeutic opportunities

Ding, H., & Fisher, D. E. (2002) · Annals of Medicine · doi:10.1080/078538902321012405 · Cited by 44

The alternative reading frame tumor suppressor inhibits growth through p21-dependent and p21-independent pathways.

Modestou, M., Puig-Antich, V., Korgaonkar, C. K., Eapen, A. K., & Quelle, D. E. (2001) · PubMed · Cited by 44

Functional and Physical Interaction of the Human ARF Tumor Suppressor with Tat-binding Protein-1

Pollice, A., Nasti, V., Ronca, R., Vivo, M., Iacono, M. L., Calogero, R., Calabrò, V., & Mantia, G. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310957200 · Cited by 46

Transgenic and Knockout Mice Models to Reveal the Functions of Tumor Suppressor Genes

Taneja, P., Zhu, S., Maglic, D., Fry, E. A., Kendig, R. D., & Inoue, K. (2011) · Clinical Medicine Insights Oncology · doi:10.4137/cmo.s7516 · Cited by 44

p53, SKP2, and DKK3 as MYCN Target Genes and Their Potential Therapeutic Significance

Chen, L., & Tweddle, D. A. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00173 · Cited by 43

Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis

Liu, S., Tackmann, N. R., Yang, J., & Zhang, Y. (2016) · Oncogene · doi:10.1038/onc.2016.301 · Cited by 43

Jumonji domain‐containing protein 6 protein and its role in cancer

Yang, J., Chen, S., Yang, Y., Ma, X., Shao, B., Yang, S., Wei, Y., & Wei, X. (2020) · Cell Proliferation · doi:10.1111/cpr.12747 · Cited by 45

Co-Operativity between MYC and BCL-2 Pro-Survival Proteins in Cancer

Fairlie, W. D., & Lee, E. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062841 · Cited by 45

RRM2B Suppresses Activation of the Oxidative Stress Pathway and is Up-regulated by P53 During Senescence

Kuo, M.-L., Sy, A. J., Xue, L., Chi, M., Lee, M. T. C., Yen, T., Chiang, M.-I., Chang, L., Chu, P. G., & Yen, Y. (2012) · Scientific Reports · doi:10.1038/srep00822 · Cited by 44

MYC Degradation under Low O 2 Tension Promotes Survival by Evading Hypoxia-Induced Cell Death

Wong, W. J., Qiu, B., Nakazawa, M. S., Qing, G., & Simon, M. C. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00853-12 · Cited by 43

Cooperative Role of the RNA-Binding Proteins Hzf and HuR in p53 Activation

Nakamura, H., Kawagishi, H., Watanabe, A., Sugimoto, K., Maruyama, M., & Sugimoto, M. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01424-10 · Cited by 45

ARF mutation accelerates pituitary tumor development in Rb +/− mice

Tsai, K. Y., MacPherson, D. P., Rubinson, D. A., Nikitin, A. Y., Bronson, R. T., Mercer, K. L., Crowley, D. G., & Jacks, T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.262499599 · Cited by 43

Oncogenic Protein MTBP Interacts with MYC to Promote Tumorigenesis

Grieb, B. C., Gramling, M., Arrate, M. P., Chen, X., Beauparlant, S. L., Haines, D. S., Xiao, H., & Eischen, C. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2149 · Cited by 42

Telomere Shortening Alters the Kinetics of the DNA Damage Response after Ionizing Radiation in Human Cells

Drissi, R., Wu, J., Hu, Y., Bockhold, C. A., & Dome, J. S. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0069 · Cited by 42

Nfkb1 is dispensable for Myc-induced lymphomagenesis

Keller, U. B., Nilsson, J. A., Maclean, K. H., Old, J. B., & Cleveland, J. L. (2005) · Oncogene · doi:10.1038/sj.onc.1208779 · Cited by 42

Animal models of melanoma: Recent advances and future prospects

Bardeesy, N. M., Wong, K., DePinho, R. A., & Chin, L. (2000) · Advances in cancer research · doi:10.1016/s0065-230x(00)79004-x · Cited by 43

Role of Retinoblastoma Tumor Suppressor Protein in DNA Damage Response

Wang, S. N. J. Y. J. (2001) · Acta Oncologica · doi:10.1080/02841860152619098 · Cited by 42

Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model of lymphomagenesis

Bieging-Rolett, K. T., Amick, A. C., & Longnecker, R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907994106 · Cited by 41

Arf tumor suppressor disrupts the oncogenic positive feedback loop including c-Myc and DDX5

Tago, K., Funakoshi‐Tago, M., Itoh, H., Furukawa, Y., Kikuchi, J., Kato, T., Suzuki, K., & Yanagisawa, K. (2014) · Oncogene · doi:10.1038/onc.2013.561 · Cited by 41

The role of MYC in the transformation and aggressiveness of ‘indolent’ B-cell malignancies

Filip, D., & Mráz, M. (2019) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2019.1675877 · Cited by 44

c-Myc, Genomic Instability and Disease

Kuttler, F., & Mai, S. (2006) · KARGER eBooks · doi:10.1159/000092507 · Cited by 43

A Non-Tumor Suppressor Role for Basal p19ARF in Maintaining Nucleolar Structure and Function

Apicelli, A. J., Maggi, L. B., Hirbe, A. C., Miceli, A. P., Olanich, M. E., Winkeler, C. L., Saporita, A. J., Kuchenreuther, M., Sanchez, J., Weilbaecher, K. N., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00484-07 · Cited by 41

MIF loss impairs Myc-induced lymphomagenesis

Talos, F., Mena, P., Fingerle‐Rowson, G., Moll, U. M., & Petrenko, O. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401653 · Cited by 41

AtmDeficiency Affects Both Apoptosis and Proliferation to Augment Myc-Induced Lymphomagenesis

Maclean, K. H., Kastan, M. B., & Cleveland, J. L. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0058 · Cited by 43

The c-MYC oncoprotein as a treatment target in cancer and other disorders of cell growth

Pelengaris, S., & Khan, M. (2003) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.7.5.623 · Cited by 41

p14ARF is a component of the p53 response following ionizing irradiation of normal human fibroblasts

Khan, S. H., Guevara, C. I., Fujii, G., & Parry, D. (2004) · Oncogene · doi:10.1038/sj.onc.1207824 · Cited by 41

Loss of the p21(Cip1/Waf1) cyclin kinase inhibitor results in propagation of horizontally transferred DNA.

Bergsmedh, A., Szeles, A., Spetz, A., & Holmgren, L. (2002) · PubMed · Cited by 41

Loss of p21 disrupts p14ARF-induced G1 cell cycle arrest but augments p14ARF-induced apoptosis in human carcinoma cells

Hemmati, P., Normand, G., Verdoodt, B., von Haefen, C., Hasenjäger, A., Güner, D., Wendt, J., Dörken, B., & Daniel, P. T. (2005) · Oncogene · doi:10.1038/sj.onc.1208579 · Cited by 40

MYC and RAF: Key Effectors in Cellular Signaling and Major Drivers in Human Cancer

Stefan, E., & Bister, K. (2017) · Current topics in microbiology and immunology · doi:10.1007/82_2017_4 · Cited by 40

Specific Contribution of p19ARF to Nitric Oxide-Dependent Apoptosis

Zeini, M., Través, P. G., López-Fontal, R., Pantoja, C., Matheu, A., Serrano, M., Boscá, L., & Hortelano, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.3327 · Cited by 40

Inhibitory effect of c-Myc on p53-induced apoptosis in leukemia cells. Microarray analysis reveals defective induction of p53 target genes and upregulation of chaperone genes

Ceballos, E., Muñoz-Alonso, M. J., Berwanger, B., Acosta, J. C., Hernández, R., Krause, M., Hartmann, O., Eilers, M., & León, J. (2005) · Oncogene · doi:10.1038/sj.onc.1208652 · Cited by 43

The Arf tumor suppressor protein inhibits Miz1 to suppress cell adhesion and induce apoptosis

Herkert, B., Dwertmann, A., Herold, S., Abed, M., Naud, J., Finkernagel, F., Harms, G. S., Orian, A., Wanzel, M., & Eilers, M. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.200908103 · Cited by 40

Loss of Bax alters tumor spectrum and tumor numbers in ARF-deficient mice.

Eischen, C. M., Rehg, J. E., Korsmeyer, S. J., & Cleveland, J. L. (2002) · PubMed · Cited by 40

Antagonism of Myc functions by Arf

Cleveland, J. L., & Sherr, C. J. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.020 · Cited by 40

p53 Mediates Apoptotic Crisis in Primary Abelson Virus-Transformed Pre-B Cells

Unnikrishnan, I., Radfar, A., Jenab-Wolcott, J., & Rosenberg, N. E. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.4825 · Cited by 40

In vitro genetic screen identifies a cooperative role for LPA signaling and c-Myc in cell transformation

Taghavi, P., Verhoeven, E., Jacobs, J. J. L., Lambooij, J.-P., Stortelers, C., Tanger, E., Moolenaar, W. H., & van Lohuizen, M. (2008) · Oncogene · doi:10.1038/onc.2008.294 · Cited by 40

p53 Binds to and Is Required for the Repression of Arf Tumor Suppressor by HDAC and Polycomb

Zeng, Y., Kotake, Y., Pei, X., Smith, M. D., & Xiong, Y. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3483 · Cited by 41

Pin1 is required for sustained B cell proliferation upon oncogenic activation of Myc

D’Artista, L., Bisso, A., Piontini, A., Doni, M., Verrecchia, A., Kress, T. R., Morelli, M. J., Sal, G. D., Amati, B. B., & Campaner, S. (2016) · Oncotarget · doi:10.18632/oncotarget.7846 · Cited by 40

CRL2-KLHDC3 E3 ubiquitin ligase complex suppresses ferroptosis through promoting p14ARF degradation

Zhang, P., Gao, K., Zhang, L., Sun, H., Zhao, X., Liu, Y., Lv, Z., Shi, Q., Chen, Y., Jiao, D., et al. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00890-0 · Cited by 39

ARF Suppresses Tumor Angiogenesis through Translational Control of VEGFA mRNA

Kawagishi, H., Nakamura, H., Maruyama, M., Mizutani, S., Sugimoto, K., Takagi, M., & Sugimoto, M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0368 · Cited by 39

Epigenetic Down-Regulation of ARF Expression Is a Selection Step in Immortalization of Human Fibroblasts by c-Myc

Benanti, J. A., Wang, M. L., Myers, H. E., Robinson, K. L., Grandori, C., & Galloway, D. A. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0372 · Cited by 39

AP4 directly downregulates p16 and p21 to suppress senescence and mediate transformation

Jackstadt, R., Jung, P., & Hermeking, H. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.282 · Cited by 41

KDM6A addiction of cervical carcinoma cell lines is triggered by E7 and mediated by p21CIP1 suppression of replication stress

Soto, D. R., Barton, C. E., Münger, K., & McLaughlin-Drubin, M. E. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006661 · Cited by 41

A critical role for Mnt in Myc-driven T-cell proliferation and oncogenesis

Link, J. M., Ota, S., Zhou, Z.-Q., Daniel, C. J., Sears, R. C., & Hurlin, P. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206406109 · Cited by 38

Hallmarks for senescence in carcinogenesis: novel signaling players

Caino, M. C., Meshki, J., & Kazanietz, M. G. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0316-z · Cited by 40

ARF Tumor Suppressor Induces Mitochondria-dependent Apoptosis by Modulation of Mitochondrial Bcl-2 Family Proteins

Nakazawa, Y., Kamijo, T., Koike, K., & Noda, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300510200 · Cited by 38

Protein Kinase CK2 Is a Central Regulator of Topoisomerase I Hyperphosphorylation and Camptothecin Sensitivity in Cancer Cell Lines

Bandyopadhyay, K., & Gjerset, R. A. (2010) · Biochemistry · doi:10.1021/bi101110e · Cited by 37

ATM activity contributes to the tumor-suppressing functions of p14ARF

Li, Y., Wu, D., Chen, B., Ingram, A. J., He, L., Liu, L., Zhu, D., Kapoor, A., & Tang, D. (2004) · Oncogene · doi:10.1038/sj.onc.1207957 · Cited by 37

Linking of N-Myc to Death Receptor Machinery in Neuroblastoma Cells

Cui, H., Li, T., & Ding, H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410450200 · Cited by 37

Mouse model for probing tumor suppressor activity of protein phosphatase 2A in diverse signaling pathways

Walter, G., & Ruediger, R. (2012) · Cell Cycle · doi:10.4161/cc.11.3.19057 · Cited by 38

Myc, Cdk2 and cellular senescence: Old players, new game

Campaner, S., Doni, M., Verrecchia, A., Fagà, G., Bianchi, L., & Amati, B. B. (2010) · Cell Cycle · doi:10.4161/cc.9.18.13049 · Cited by 39

Role of the alternating reading frame (P19)-p53 pathway in an in vivo murine colon tumor model.

Nambiar, P. R., Giardina, C. A., Guda, K., Aizu, W., Raja, R. G., & Rosenberg, D. W. (2002) · PubMed · Cited by 37

Inhibition of v-Abl transformation by p53 and p19ARF

Cong, F., Zou, X., Hinrichs, K., Calame, K. L., & Goff, S. P. (1999) · Oncogene · doi:10.1038/sj.onc.1203290 · Cited by 38

E2F-1 induces the stabilization of p53 but blocks p53-mediated transactivation

Nip, J., Strom, D. K., Eischen, C. M., Cleveland, J. L., Zambetti, G. P., & Hiebert, S. W. (2001) · Oncogene · doi:10.1038/sj.onc.1204171 · Cited by 37

mTORC2 promotes cell survival through c-Myc–dependent up-regulation of E2F1

Zou, Z., Chen, J., Liu, A., Zhou, X., Song, Q., Jia, C., Chen, Z., Lin, J., Yang, C., Li, M., et al. (2015) · The Journal of Cell Biology · doi:10.1083/jcb.201411128 · Cited by 36

Myc sensitizes p53-deficient cancer cells to the DNA-damaging effects of the DNA methyltransferase inhibitor decitabine

Höglund, A., Nilsson, L. M., Forshell, L. P., Maclean, K. H., & Nilsson, J. A. (2009) · Blood · doi:10.1182/blood-2008-10-183475 · Cited by 36

MYC, Cell Competition, and Cell Death in Cancer: The Inseparable Triad

Giacomo, S. D., Sollazzo, M., Paglia, S., & Grifoni, D. (2017) · Genes · doi:10.3390/genes8040120 · Cited by 36

Targeting Mouse Double Minute 2: Current Concepts in DNA Damage Repair and Therapeutic Approaches in Cancer

Li, W., Peng, X., Lang, J., & Xu, C. S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00631 · Cited by 36

Intrinsically Unstructured Domains of Arf and Hdm2 Form Bimolecular Oligomeric Structures In Vitro and In Vivo

Sivakolundu, S. G., Nourse, A., Moshiach, S., Bothner, B. B., Ashley, C., Satumba, J., Lahti, J. M., & Kriwacki, R. W. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.09.019 · Cited by 36

Expression of p14, MDM2, and MDM4 in human retinoblastoma

Guo, Y., Pajovic, S., & Gallie, B. L. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.07.055 · Cited by 36

TGF-β-Mediated Cell Cycle Arrest of HPV16-Immortalized Human Ectocervical Cells Correlates with Decreased E6/E7 mRNA and Increased p53 and p21WAF-1 Expression

Rorke, E. A., Zhang, D., Choo, C. K., Eckert, R. L., & Jacobberger, J. W. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4953 · Cited by 36

Myc Prevents Apoptosis and Enhances Endoreduplication Induced by Paclitaxel

Gatti, G., Maresca, G., Natoli, M., Florenzano, F., Nicolin, A., Felsani, A., & D’Agnano, I. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005442 · Cited by 37

FBXW7 and the Hallmarks of Cancer: Underlying Mechanisms and Prospective Strategies

Shen, W., Zhou, Q., Peng, C., Li, J., Yuan, Q., Zhu, H., Zhao, M., Jiang, X., Liu, W., & Ren, C. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.880077 · Cited by 40

Activation of ARF by oncogenic stress in mouse fibroblasts is independent of E2F1 and E2F2

Palmero, I., Murga, M., Zubiaga, A. M., & Serrano, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205371 · Cited by 35

Effects of a glycogen synthase kinase-3β inhibitor (LiCl) on c-myc protein in intervertebral disc cells

Hiyama, A., Sakai, D., Arai, F., Nakajima, D., Yokoyama, K., & Mochida, J. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23217 · Cited by 35

Expression of Arf Tumor Suppressor in Spermatogonia Facilitates Meiotic Progression in Male Germ Cells

Churchman, M. L., Roig, I., Jasin, M., Keeney, S., & Sherr, C. J. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002157 · Cited by 35

MTBP Is Overexpressed in Triple-Negative Breast Cancer and Contributes to Its Growth and Survival

Grieb, B. C., Chen, X., & Eischen, C. M. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0069 · Cited by 35

Gliomagenesis Arising from Pten- and Ink4a/Arf-Deficient Neural Progenitor Cells Is Mediated by the p53-Fbxw7/Cdc4 Pathway, Which Controls c-Myc

Kim, H. S., Woolard, K., Lai, C., Bauer, P. O., Maric, D., Song, H., Li, A., Kotliarova, S. E., Zhang, W., & Fine, H. A. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2594 · Cited by 36

Mnt-Deficient Mammary Glands Exhibit Impaired Involution and Tumors with Characteristics of Myc Overexpression

Toyo‐oka, K., Bowen, T. J., Hirotsune, S., Li, Z., Jain, S., Ota, S., Escoubet‐Lozach, L., García-Bassets, I., Lozach, J., Rosenfeld, M. G., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2683 · Cited by 35

c-Myc-mediated Regulation of Telomerase Activity Is Disabled in Immortalized Cells

Drissi, R., Zindy, F., Roussel, M. F., & Cleveland, J. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101899200 · Cited by 35

Mdm2 Phosphorylation Regulates Its Stability and Has Contrasting Effects on Oncogene and Radiation-Induced Tumorigenesis

Carr, M. I., Roderick, J. E., Gannon, H., Kelliher, M. A., & Jones, S. N. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.014 · Cited by 34

AF5, a CNS Cell Line Immortalized with an N-Terminal Fragment of SV40 Large T: Growth, Differentiation, Genetic Stability, and Gene Expression

Truckenmiller, M. E., Vawter, M. P., Zhang, P., Conejero-Goldberg, C., Dillon‐Carter, O., Morales, N., Cheadle, C., Becker, K. G., & Freed, W. J. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7898 · Cited by 34

Modeling and Targeting MYC Genes in Childhood Brain Tumors

Hutter, S., Bolin, S., Weishaupt, H., & Swartling, F. J. (2017) · Genes · doi:10.3390/genes8040107 · Cited by 38

Apoptosis in atherosclerosis: pathological and pharmacological implications

Guevara, J., Chen, K.-H., & Chan, L. (2001) · Pharmacological Research · doi:10.1006/phrs.2001.0840 · Cited by 34

Hzf, a p53-Responsive Gene, Regulates Maintenance of the G2 Phase Checkpoint Induced by DNA Damage

Sugimoto, M., Gromley, A., & Sherr, C. J. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.26.2.502-512.2006 · Cited by 35

Wild-type and Hupki (Human p53 Knock-in) Murine Embryonic Fibroblasts

Whibley, C. E., Odell, A. F., Nedelko, T., Balaburski, G. M., Murphy, M. E., Liu, Z., Stevens, L., Walker, J. H., Routledge, M. N., & Hollstein, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.064444 · Cited by 33

Smarcal1 and Zranb3 Protect Replication Forks from Myc-Induced DNA Replication Stress

Puccetti, M. V., Adams, C. M., Kushinsky, S., & Eischen, C. M. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2705 · Cited by 35

MDM2 as MYCN transcriptional target: Implications for neuroblastoma pathogenesis

Slack, A., Lozano, G., & Shohet, J. M. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.01.050 · Cited by 33

Apigenin induces c-Myc-mediated apoptosis in FRO anaplastic thyroid carcinoma cells

Kim, S. H., Kang, J. G., Kim, C. S., Ihm, S., Choi, M. G., Yoo, H. J., & Lee, S. J. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.01.012 · Cited by 33

Dynamics of ARF regulation that control senescence and cancer

Ko, A., Han, S. Y., & Song, J. (2016) · BMB Reports · doi:10.5483/bmbrep.2016.49.11.120 · Cited by 35

Zinc enhances CDKN2A , pRb1 expression and regulates functional apoptosis via upregulation of p53 and p21 expression in human breast cancer MCF-7 cell

Al-Saran, N., Subash‐Babu, P., Al-Nouri, D. M., Alfawaz, H., & Alshatwi, A. A. (2016) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2016.08.002 · Cited by 33

Limited role of N-terminal phosphoserine residues in the activation of transcription by p53

Jackson, M. W., Agarwal, M. K., Agarwal, M. L., Agarwal, A. M., Stanhope-Baker, P., Williams, B. R. G., & Stark, G. R. (2004) · Oncogene · doi:10.1038/sj.onc.1207575 · Cited by 33

Repression of SRF target genes is critical for Myc‐dependent apoptosis of epithelial cells

Wiese, K. E., Haikala, H. M., von Eyß, B., Wolf, E., Esnault, C., Rosenwald, A., Treisman, R., Klefström, J. T., & Eilers, M. (2015) · The EMBO Journal · doi:10.15252/embj.201490467 · Cited by 32

Myc suppression of Nfkb2 accelerates lymphomagenesis

Keller, U. B., Huber, J., Nilsson, J. A., Fallahi, M., Hall, M. A., Peschel, C., & Cleveland, J. L. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-348 · Cited by 32

Tumor-associated antigen Prame targets tumor suppressor p14/ARF for degradation as the receptor protein of CRL2Prame complex

Zhang, W., Li, L., Cai, L., Liang, Y., Xu, J., Liu, Y., Zhou, L., Ding, C., Zhang, Y., Zhao, H., et al. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-020-00724-5 · Cited by 32

Metabolic Effects of Recurrent Genetic Aberrations in Multiple Myeloma

Bloedjes, T. A., de Wilde, G., & Guikema, J. E. J. (2021) · Cancers · doi:10.3390/cancers13030396 · Cited by 32

Arf tumor suppressor and miR-205 regulate cell adhesion and formation of extraembryonic endoderm from pluripotent stem cells

Li, C., Finkelstein, D., & Sherr, C. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1302184110 · Cited by 32

Loss of one allele of ARF rescues Mdm2 haploinsufficiency effects on apoptosis and lymphoma development

Eischen, C. M., Alt, J. R., & Wang, P. (2004) · Oncogene · doi:10.1038/sj.onc.1208052 · Cited by 32

Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis

Eischen, C. M., Weber, J. D., Roussel, M. F., Sherr, C. J., & Cleveland, J. L. (1999) · Genes & Development · doi:10.1101/gad.13.20.2658 · Cited by 819

Regulation of Myc function by ARF: Checkpoint for Myc-induced oncogenesis

Sarkar, D., & Fisher, P. B. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.6.2939 · Cited by 6

Abstract A40: Investigating the functional response of the ARF tumor suppressor to acute p53 loss

Forys, J. T., Kladney, R. D., & Weber, J. D. (2011) · Cancer Research · doi:10.1158/1538-7445.fbcr11-a40

p19ARF directly and differentially controls the functions of c-Myc independently of p53

Qi, Y., Gregory, M. A., Li, Z., Brousal, J. P., West, K. A., & Hann, S. (2004) · Nature · doi:10.1038/nature02958 · Cited by 214

Epigenetic Down-Regulation of ARF Expression Is a Selection Step in Immortalization of Human Fibroblasts by c-Myc

Benanti, J. A., Wang, M. L., Myers, H. E., Robinson, K. L., Grandori, C., & Galloway, D. A. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0372 · Cited by 39